Hyphens Pharma International (SGX:1J5) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:1J5 Hyphens Pharma International Ltd SGX:1J5
82 GF Score
Price S$0.36
GF Value S$0.31
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Hyphens Pharma International Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SGX:1J5 vs MCK, COR, CAH: Short Interest Comparison

For the Medical Distribution subindustry, Hyphens Pharma International's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyphens Pharma International Short Interest vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hyphens Pharma International's Short Interest distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's Short Interest falls into.


SGX:1J5
82GF Score
Hyphens Pharma International Ltd SGX:1J5
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hyphens Pharma International (SGX:1J5) Overvalued in 2026?

Based on GuruFocus' analysis, Hyphens Pharma International stock appears to be overvalued. The current stock price of S$0.36 is trading 16.1% above its estimated GF Value™ of S$0.31. GuruFocus considers Hyphens Pharma International to be Modestly Overvalued.

Key valuation signals for SGX:1J5:

  • Short Interest:
  • GF Value™: S$0.31 vs. price of S$0.36 (16.1% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SGX:1J5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hyphens Pharma International Business Description

Address 16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include the Pharmaceutical and Medical Aesthetics segment; Proprietary Brands segment; and Digital Platform and E-Pharmacy segment. The Pharmaceutical and Medical Aesthetics segment engages in the business of marketing and selling a range of pharmaceutical and medical aesthetics products with exclusivity in the relevant ASEAN countries. The Proprietary Brands segment develops, markets, and sells dermatological, pharmaceuticals and health supplement products. The Digital Platform and E-Pharmacy segment is a digital platform servicing procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies, mainly in Singapore.
82GF Score

Get the complete analysis for SGX:1J5

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.36
Price
S$0.31
GF Value